...
首页> 外文期刊>Talanta: The International Journal of Pure and Applied Analytical Chemistry >Spectrofluorimetric study of the β-cyclodextrin-ibuprofen complex and determination of ibuprofen in pharmaceutical preparations and serum
【24h】

Spectrofluorimetric study of the β-cyclodextrin-ibuprofen complex and determination of ibuprofen in pharmaceutical preparations and serum

机译:β-环糊精-布洛芬复合物的荧光光谱法研究及药物制剂和血清中布洛芬的测定

获取原文
获取原文并翻译 | 示例
           

摘要

The inclusion complexation of ibuprofen in β-cyclodextrin (β-CD) has been examined by means of spectrofluorimetry at both acid and alkaline pH. The results suggest that stable 1:1 complexes are formed in both media. The analysis of the pK_a values for ibuprofen in both the absence and presence of β-CD (4.12 and 4.66, respectively) suggests that in the inclusion complex the carboxylic group is located outside the cyclodextrin (CD) but interacting with it. Further structural characterization of the complex was carried out by means of AM1 semiempiral calculations. Based on the obtained results, a spectrofluorimetric method for the determination of ibuprofen in the presence of β-CD at 10 ℃ was developed in the range of 4.7-58 μg ml~(-1). Better limits of detection (1.6 μg ml~(-1)) and quantification (4.7 μg ml~(-1)) were obtained in this latter case with respect to those obtained in the absence of β-CD. The method was satisfactorily applied to the quantification of ibuprofen in pharmaceutical preparations. A novel spectrofluorimetric determination of ibuprofen in the presence of β-CD was also developed for serum samples at concentration levels between 5 and 70 μg ml~(-1). It uses second-order fluorescence excitation-emissions matrices coupled to an algorithm based on self-weighted alternating trilinear decomposition (SWATLD), and avoids resorting to separative instrumental analyses.
机译:已通过在酸性和碱性pH值下的荧光光谱法研究了布洛芬在β-环糊精(β-CD)中的包合物。结果表明在两种介质中均形成稳定的1:1复合物。在不存在和存在β-CD的情况下,布洛芬的pK_a值分析(分别为4.12和4.66)表明,在包合物中,羧基位于环糊精(CD)外部但与之相互作用。借助AM1半经验计算对复合物进行进一步的结构表征。基于得到的结果,建立了在10℃存在β-CD的荧光荧光法测定布洛芬的范围为4.7-58μgml〜(-1)。与在没有β-CD的情况下获得的检测限相比,在后一种情况下获得了更好的检测限(1.6μgml〜(-1))和定量(4.7μgml〜(-1))。该方法已令人满意地应用于药物制剂中布洛芬的定量分析。还开发了一种新型的荧光荧光测定法,用于在浓度为5至70μgml〜(-1)的血清样品中存在β-CD时。它结合了基于自加权交替三线性分解(SWATLD)的算法的二阶荧光激发发射矩阵,并且避免了使用分离的仪器分析方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号